All Stories

  1. Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches
  2. 3 Questions on...Cancer Care Disparities in LGBTI Communities
  3. The relationships between patient volume per oncologist, social worker presence, and capacity to provide psychosocial care.
  4. The Relationship of Obesity to Hospice Use and Expenditures
  5. The Power of the Placebo in Symptom Management
  6. Interview Topic Guide on Sexual Health Needs in Metastatic Breast Cancer
  7. Health Disparities and the Cancer Survivor
  8. Marginal treatment benefit in anaplastic thyroid cancer
  9. Referral Patterns for Patients with High-Risk Thyroid Cancer
  10. Life-Threatening Disparities: The Treatment of Black and White Cancer Patients
  11. Deep Time: The Long and the Short of Adjuvant Endocrine Therapy for Breast Cancer
  12. Role of Nonclinical Factors in the Receipt of High-Quality Systemic Adjuvant Breast Cancer Treatment
  13. The impact of diabetes on survival in women with ovarian cancer
  14. Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: A study from the NHANES
  15. Study Protocol: A randomized controlled trial of patient navigation-activation to reduce cancer health disparities
  16. Adjuvant Hormonal Therapy for Early-Stage Breast Cancer
  17. Race/Ethnicity-Based Concerns Over Understanding Cancer Diagnosis and Treatment Plan
  18. Solid Tumors
  19. Central Nervous System Tumors
  20. Cancer Epidemiology and Cancer Prevention
  21. Complications of Cancer and Cancer Treatment
  22. Patient-centered communication and prognosis discussions with cancer patients
  23. Disparities in Breast Cancer Adjuvant Chemotherapy: Moving Beyond Yes or No
  24. Postmastectomy radiotherapy for breast cancer
  25. Obesity and Cancer Treatment: Weighing the Evidence
  26. Cost effectiveness, chemotherapy, and the clinician
  27. Breast cancer adjuvant chemotherapy dosing in obese patients
  28. Program Surveillance after Breast Cancer Treatment: Contra
  29. Physician ratings of patient literacy: Bending over backwards?
  30. In Reply
  31. Individualized Strategy for Dosing Luteinizing Hormone–Releasing Hormone Agonists for Androgen-Independent Prostate Cancer: Identification of Outcomes and Costs
  32. Chemotherapy Dose Limits Set by Users of a Computer Order Entry System
  33. Neuropathic pain associated with non-surgical treatment of breast cancer
  34. Addressing Disparities in the Quality of Breast Cancer Chemotherapy
  35. Undertreatment of Obese Women Receiving Breast Cancer Chemotherapy
  36. Patient-centered care and breast cancer survivors’ satisfaction with information
  37. JOHN HENRYISM—THE SAME OLD SONG?
  38. Adequacy of Chemotherapy Dose Intensity Among African-American Women with HER-2/neu-Positive Breast Cancer
  39. Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer
  40. Economic analysis of expensive technologies
  41. Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia
  42. Reducing the toxicity of anticancer therapy: new strategies
  43. Skeletal muscle mass in an asymptomatic male
  44. Chronic inflammatory demyelinating polyneuropathy in non‐Hodgkin's lymphoma
  45. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid
  46. Social and Racial Disparities in Chemotherapy Prescribing